Annual blood test detects early pancreatic cancer efficiently

Summary: A simplified multi-omics testing using one annual blood sample can detect early pancreatic cancer. The longitudinal multi-omics monitoring (LMOM) system is practical, requiring fewer measurements and enabling faster decision-making. Researchers at the University of Alberta developed this cost-effective method, successfully diagnosing a precancerous pancreatic tumor in a 62-year-old woman. This approach has also identified early cardiovascular disease and Type 2 diabetes in other cases.

Full article